Ownership of Licensed Patents. Licensor will at all times be the sole owner of all right, title, and interest (including intellectual property rights) in and to the Licensed Patents.
Ownership of Licensed Patents. The Company shall exclusively own all rights in and to the Licensed Patents and the Technology, including patent rights, trade secrets, copyrights and other intellectual property rights.
Ownership of Licensed Patents. PERIMMUNE shall have sole and exclusive ownership of the Licensed Patents subject to SIGMA'S exclusive worldwide license as provided in Article IV hereof.
Ownership of Licensed Patents. The Licensee acknowledges that the Licensed Patents, except with respect to Licensed Products, are the sole property of the Licensor and that the Licensor has the exclusive right to control and license the Licensed Patents and agrees that it will not dispute or contest the Licensor’s interest therein.
Ownership of Licensed Patents. The Patent Owners are the registered proprietors of the Patents and own all right, title and interest to the Licensed Patents, free and clear of any liens, charges or other encumbrances. The Patent owners have not done or omitted nor will hereafter do or omit any act or thing whatsoever whereby the Licensed Patents may be invalidated, encumbered or otherwise prejudicially affected or the due performance of this Agreement hindered or prevented.
Ownership of Licensed Patents. PROPRIETARY AND CONFIDENTIAL INFORMATION ----------------------------------------
12.01 Rofin acknowledges that all information and material supplied to Rofin under this Agreement shall remain the sole property of Boreal.
12.02 The parties acknowledge that all information supplied under this Agreement shall remain the sole property of the transmitting party.
12.03 The receiving party will keep confidential the information received from the other party and not use such information for any purposes except as contemplated in this Agreement. This obligation, however, does not apply to information which the receiving party can prove:
(a) to be freely available from the public domain;
(b) it had owned prior to receipt from the transmitting party;
(c) to have legally received from a third party without obligation of confidence; or
(d) to have developed independently from the information developed from the other party.
12.04 Rofin shall be entitled to transmit confidential information received from Boreal under this Agreement to its sublicencees after the sublicencees have bound themselves to the same obligations of confidence as stipulated above. Rofin shall provide Boreal with copies of all contractual or other commitments by such sublicencees in this regard.
Ownership of Licensed Patents. Subject to Section 2.1, as between the Parties, Illumina shall own and retain all right, title and interest in and to the Licensed Patents.
Ownership of Licensed Patents. MVS and Dr. Madan represent to XsunX that xxxx, xxintly or severally, own the Licensed Patents and Technology free and clear of any claim, charge, or lien, possess the right to grant the License hereunder, and have received no notice that the Licensed Patents and Technology are not valid or infringe in any way on the intellectual property rights of any party.
Ownership of Licensed Patents. UBS hereby acknowledges that, except as otherwise provided herein, the Enron Parties retain all right, title and interest in and to the Licensed Patents and that UBS's use of the Licensed Patents shall not create in UBS any right, title and interest in the Licensed Patents, except as a licensee, and that all use of the Licensed Patents will inure solely to the benefit of the Enron Parties.
Ownership of Licensed Patents. BioMarin, or its Affiliates, are, and throughout the Term will remain, the sole and exclusive owners of all rights, title and interests in and to the Licensed Patents set forth on Schedule 1.57 (Licensed Patents), free and clear of all encumbrances, except to the extent such Schedule indicates that a Third Party owns one or more of such Patents, in which case the Schedule identifies the license agreement pursuant to which such Patents are licensed to by such Third Party to BioMarin or its Affiliates.
